Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly Metronidazole and Fluconazole for Vaginal Infection Prevention
NCT00170430Phase 3Completed
- Sponsor
- University of Washington
- Start
- May 2003
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vaginitis comparing Metronidazole + Fluconazole with Placebo (2 arms). Primary endpoint: Incidence of vaginal infections at 1 year. Started May 2003; status: completed.
02
Drugs
metronidazolefluconazole
03
Conditions
vaginitis
Beyond the preview
Go deeper on NCT00170430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170430.